Join to View Full Profile
600 N Cattlemen RdSuite 200Sarasota, FL 34232
Phone+1 941-377-9993
Fax+1 941-343-0026
Dr. Kayali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Trinity Health Oakland/Wayne State UniversityResidency, Internal Medicine, 2004 - 2007
St Petersburg Medical State AcademyClass of 1997
Certifications & Licensure
FL State Medical License 2010 - 2026
OK State Medical License 2011 - 2012
KY State Medical License 2007 - 2011
MI State Medical License 2004 - 2007
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Publications & Presentations
PubMed
- 39 citationsA phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease.Kendra Sweet, Lori A. Hazlehurst, Eva Sahakian, John Powers, Lisa Nodzon
Leukemia Research. 2018-10-16 - 78 citationsVenous thromboembolism in patients hospitalized with nephrotic syndrome.Fadi Kayali, Reiad Najjar, Firas Aswad, Fadi Matta, Paul D. Stein
The American Journal of Medicine. 2008-03-01 - 24 citationsSpiral computed tomography for the diagnosis of acute pulmonary embolism.Paul D. Stein, Fadi Kayali, Russell D. Hull
Thrombosis and Haemostasis. 2007-10-01
Journal Articles
- A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of DiseaseKendra Sweet, Fadi Kayali, Javier Pinilla-Ibarz, Leukemia Research
- A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of DiseaseKendra Sweet, Fadi Kayali, Javier Pinilla-Ibarz, Leukemia Research
Authored Content
- A Phase I Clinical Trial of Ruxolitinib in Combination with Nilotinib in Chronic Myeloid Leukemia Patients with Molecular Evidence of DiseaseOctober 2018
Other Languages
- Russian, Arabic, Russian, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
